Your browser doesn't support javascript.
loading
The polo-like kinase 1 inhibitor volasertib synergistically increases radiation efficacy in glioma stem cells.
Dong, Jianwen; Park, Soon Young; Nguyen, Nghi; Ezhilarasan, Ravesanker; Martinez-Ledesma, Emmanuel; Wu, Shaofang; Henry, Verlene; Piao, Yuji; Tiao, Ningyi; Brunell, David; Stephan, Clifford; Verhaak, Roel; Sulman, Erik; Balasubramaniyan, Veerakumar; de Groot, John F.
Afiliación
  • Dong J; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Park SY; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Nguyen N; Institute of Biosciences and Technology, Texas A&M Health Science Center at Houston, Center for Translational Cancer Research, Houston, TX, USA.
  • Ezhilarasan R; Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Martinez-Ledesma E; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wu S; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Henry V; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Piao Y; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Tiao N; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Brunell D; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Stephan C; Institute of Biosciences and Technology, Texas A&M Health Science Center at Houston, Center for Translational Cancer Research, Houston, TX, USA.
  • Verhaak R; Institute of Biosciences and Technology, Texas A&M Health Science Center at Houston, Center for Translational Cancer Research, Houston, TX, USA.
  • Sulman E; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Balasubramaniyan V; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • de Groot JF; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
Oncotarget ; 9(12): 10497-10509, 2018 Feb 13.
Article en En | MEDLINE | ID: mdl-29535822
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos